StonvexLoading…
StonvexStonvexStonvexCore line items from TBCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $42.17M | $319.91M | $201.13M | $80.46M |
Operating Income | $-14.06M | $27.52M | $6.57M | $1.21M |
Net Income | $-15.21M | $15.73M | $-1.88M | $-2.93M |
EPS (Diluted) | $-0.78 | $0.77 | $-0.09 | $-0.17 |
Total Assets | $209.93M | $269.05M | $278.21M | $240.18M |
Total Liabilities | $98.07M | $140.56M | $167.56M | $123.35M |
Cash & Equivalents | $12.32M | $16.96M | $12.26M | $11.71M |
Free Cash Flow OCF − CapEx | $29.10M | $34.04M | $20.95M | $36.81M |
Shares Outstanding | 19.61M | 19.19M | 19.31M | 19.82M |